SBBP
Strongbridge Biopharma plc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Market Cap: 186 Million
Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)
Website: http://www.strongbridgebio.com/
Shares Outstanding: 67.2 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.3180803597412774
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1400 trading days
From: 2015-10-16 To: 2020-11-27
Lowest Point:
Strongbridge And Recorlev In Endogenous Cushing's Syndrome: Potential Impact On Liver Steatosis
via: SeekingAlpha at 2019-06-11 18:58:18:000
Market Assessment Strongbridge Biopharma ( SBBP ) is a small-cap ($161 million) commercial-stage biopharmaceutical company developing innovative therapies for rare diseases affecting the neuromuscular and endocrine systems (i.e., acromegaly and Cushings syndrome). Commercial products… read more...
Strongbridge And Recorlev In Endogenous Cushing's Syndrome: Potential Impact On Liver Steatosis
via: SeekingAlpha at 2019-06-11 18:58:18:000
Market Assessment Strongbridge Biopharma ( SBBP ) is a small-cap ($161 million) commercial-stage biopharmaceutical company developing innovative therapies for rare diseases affecting the neuromuscular and endocrine systems (i.e., acromegaly and Cushings syndrome). Commercial products… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|